Back in May, a study was published

suggesting that popular weight-loss drugs such as Ozempic ⁣and wegovy could

curb alcohol cravings⁢ by as much as 70%. At the time, researchers weren't

entirely sure why the GLP-1s had such⁢ a profound effect on alcohol

⁣ receptors, but that may have all changed.

A new study⁢ published Wednesday in the journal

Scientific Reports

⁤ found that GLP-1s slow the absorption of alcohol into the bloodstream, thus

minimizing its effects on the brain. it's not entirely different from what

⁢ GLP-1s do with food, which is to resemble the GLP-1 hormone and effectively

⁤ slow digestion.

GLP-1s,or glucagon-like peptide-1 ⁤receptor agonists,are a class of

medications originally developed to treat Type 2 Diabetes. Thay work by

mimicking ⁤the effects of the naturally occurring GLP-1 hormone, which

regulates blood sugar levels. This⁣ mimicking action extends to slowing

gastric emptying, meaning ⁢food and liquids, including⁣ alcohol, remain in the

stomach longer.

the study involved administering alcohol to ⁤rats both with and without⁢ GLP-1

treatment. Researchers observed that the rats treated with GLP-1s exhibited

⁤ considerably lower blood alcohol concentrations compared to the control

⁢ group. This suggests that the medications physically delay the rate at which

alcohol enters the bloodstream.